Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT02061397Phase 1/2Completed
Safety of Simvastatin in LAM and TSC
LymphangioleiomyomatosisTuberous Sclerosis Complex
Studydirector

Research Network

Collaboration Network

6 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Pennsylvania

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Joel Moss, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Moderately Similar
14 trials

Shared therapeutic areas:

LymphangioleiomyomatosisTuberous Sclerosis
Similarity Score30%

Vera P Krymskaya, PhD, MBA

University of Pennsylvania

Related
1 trials

Shared therapeutic areas:

LymphangioleiomyomatosisTuberous Sclerosis

Worked with same sponsors:

The LAM FoundationUniversity of Pennsylvania
Collaborated on 1 trial
Similarity Score24%

Frank McCormack, MD

University of Cincinnati

Related
2 trials

Shared therapeutic areas:

LymphangioleiomyomatosisTuberous Sclerosis

Worked with same sponsors:

The LAM FoundationUniversity of Pennsylvania
Collaborated on 1 trial
Similarity Score24%

Peter Bauer, Prof.Dr

Centogene GmbH

Related
2 trials

Shared therapeutic areas:

Lymphangioleiomyomatosis
Similarity Score15%

Didier BESSIS, PhD

University Hospitals of Montpellier

Related
4 trials

Shared therapeutic areas:

Tuberous Sclerosis
Similarity Score15%

Maria Molina-Molina, MD, PhD

Institut d'Investigació Biomèdica de Bellvitge

Related
2 trials

Shared therapeutic areas:

Lymphangioleiomyomatosis
Similarity Score15%

Sarina A Piha-Paul

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

Lymphangioleiomyomatosis
Similarity Score15%

Joel Moss, MD, PhD

National Heart, Lung, and Blood Institute (NHLBI)

Related
1 trials

Shared therapeutic areas:

Lymphangioleiomyomatosis
Similarity Score15%

Carlos RR Carvalho, PhD

Pulmonary Division, Heart Institute (InCor), University of Sao Paulo Medical School

Related
1 trials

Shared therapeutic areas:

Lymphangioleiomyomatosis
Similarity Score15%

Yannick Le meur, MD PhD

University Hospital, Brest

Related
4 trials

Shared therapeutic areas:

Tuberous Sclerosis
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02061397Phase 1/2StudyDirector

Safety of Simvastatin in LAM and TSC

LymphangioleiomyomatosisTuberous Sclerosis Complex
Completed

All 1 trials loaded